Organigram (OGI) Short Interest Ratio & Short Volume $1.14 -0.02 (-1.72%) Closing price 05/1/2025 04:00 PM EasternExtended Trading$1.12 -0.02 (-1.75%) As of 05/1/2025 06:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Organigram Short Interest DataOrganigram (OGI) has a short interest of 5.49 million shares, representing 6.63% of the float (the number of shares available for trading by the public). This marks a -9.70% decrease in short interest from the previous month. The short interest ratio (days to cover) is 6.5, indicating that it would take 6.5 days of the average trading volume of 706,441 shares to cover all short positions.Current Short Interest5,490,000 sharesPrevious Short Interest6,080,000 sharesChange Vs. Previous Month-9.70%Dollar Volume Sold Short$5.71 millionShort Interest Ratio6.5 Days to CoverLast Record DateApril 15, 2025Outstanding Shares126,274,000 sharesFloat Size82,780,000 sharesShort Percent of Float6.63%Today's Trading Volume220,786 sharesAverage Trading Volume706,441 sharesToday's Volume Vs. Average31% Short Selling Organigram? Sign up to receive the latest short interest report for Organigram and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOGI Short Interest Over TimeOGI Days to Cover Over TimeOGI Percentage of Float Shorted Over Time Organigram Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20255,490,000 shares $5.71 million -9.7%6.6%6.5 $1.04 3/31/20256,080,000 shares $6.14 million +17.8%7.3%7.1 $1.01 3/15/20255,160,000 shares $5.31 million -4.4%6.2%5.6 $1.03 2/28/20255,400,000 shares $6.21 million +25.6%6.5%5.4 $1.15 2/15/20254,300,000 shares $5.46 million +58.1%4.8%4.7 $1.27 1/31/20252,720,000 shares $4.08 million +1.1%3.0%3.4 $1.50 1/15/20252,690,000 shares $4.14 million -3.9%3.0%4 $1.54 12/31/20242,800,000 shares $4.51 million +4.1%3.3%4.2 $1.61 12/15/20242,690,000 shares $3.98 million +3.1%3.6%4.3 $1.48 11/30/20242,610,000 shares $3.94 million -5.1%3.4%5.1 $1.51 Get the Latest News and Ratings for OGI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Organigram and its competitors with MarketBeat's FREE daily newsletter. 11/15/20242,750,000 shares $3.96 million +20.1%3.6%5.9 $1.44 10/31/20242,290,000 shares $3.92 million -8.4%3.0%4.3 $1.71 10/15/20242,500,000 shares $4.33 million +1.6%3.3%4.7 $1.73 9/30/20242,460,000 shares $4.45 million -8.9%3.3%4.3 $1.81 9/15/20242,700,000 shares $5.02 million -3.2%3.6%4.5 $1.86 8/31/20242,790,000 shares $5.16 million -19.6%3.8%4.5 $1.85 8/15/20243,470,000 shares $6.91 million -5.7%4.6%5 $1.99 7/31/20243,680,000 shares $6.18 million -5.9%4.9%5.2 $1.68 7/15/20243,910,000 shares $6.69 million +0.8%5.2%4.2 $1.71 6/30/20243,880,000 shares $5.98 million -0.5%5.2%3.7 $1.54 6/15/20243,900,000 shares $5.95 million +2.6%5.2%2.6 $1.53 5/31/20243,800,000 shares $6.50 million -10.0%5.3%2.4 $1.71 5/15/20244,220,000 shares $8.14 million +9.3%5.8%2.7 $1.93 4/30/20243,860,000 shares $8.18 million +7.8%5.9%2.5 $2.12 4/15/20243,580,000 shares $6.73 million +0.3%5.4%2.5 $1.88 3/31/20243,570,000 shares $7.68 million +0.6%5.4%2.5 $2.15 3/15/20243,550,000 shares $7.35 million -0.3%5.4%3.4 $2.07 2/29/20243,560,000 shares $7.37 million -14.6%5.4%3.9 $2.07 2/15/20244,170,000 shares $8.38 million +4.0%6.8%4.8 $2.01 1/31/20244,010,000 shares $6.66 million +1.5%7.6%4.6 $1.66 1/15/20243,950,000 shares $6.68 million +2.1%6.0%2.9 $1.69 12/31/20233,870,000 shares $5.07 million -7.9%5.9%3.2 $1.31 12/15/20234,200,000 shares $5.59 million -1.2%6.4%3.5 $1.33 11/30/20234,250,000 shares $5.44 million +1.2%6.5%3.5 $1.28 11/15/20234,200,000 shares $5.25 million +30.8%6.4%3.4 $1.25 10/31/20233,210,000 shares $3.37 million +6.6%4.9%2.7 $1.05 10/15/20233,010,000 shares $3.46 million +7.1%4.6%6.1 $1.15 9/30/20232,810,000 shares $3.71 million No Change4.3%4.7 $1.32 9/15/20232,810,000 shares $5.11 million +7.7%4.3%4.7 $1.82 8/31/20232,610,000 shares $4.28 million +17.6%4.0%4.9 $1.64Silicon Valley Gold Rush (Ad)A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.Gates and Altman are betting big—see why 8/15/20232,220,000 shares $2.93 million -11.2%3.4%4.8 $1.32 7/31/20232,500,000 shares $3.80 million +3.7%3.8%5.7 $1.52 7/15/20232,410,000 shares $3.76 million +1.3%3.7%6.4 $1.56 6/30/20232,380,000 shares $3.71 million -73.9%N/A7.8 $1.56 6/15/20239,120,000 shares $3.76 million -14.6%N/A8.9 $0.41 5/31/202310,680,000 shares $3.96 million +22.1%N/A10.4 $0.37 5/15/20238,750,000 shares $4.11 million No ChangeN/A10.3 $0.47 4/30/20238,750,000 shares $4.38 million +26.1%N/A10.6 $0.50 4/15/20236,940,000 shares $3.85 million +7.9%N/A7.8 $0.56 3/31/20236,430,000 shares $4.12 million -0.3%N/A6.1 $0.64 3/15/20236,450,000 shares $4.13 million -3.3%N/A6 $0.64 2/28/20236,670,000 shares $5.26 million +23.8%N/A5.7 $0.79 2/15/20235,390,000 shares $4.54 million -11.8%N/A4.3 $0.84 1/31/20236,110,000 shares $5.55 million -1.0%N/A4.8 $0.91 1/15/20236,170,000 shares $6.11 million -17.0%N/A4.9 $0.99 12/30/20227,430,000 shares $5.94 million -4.6%N/A6.6 $0.80 12/15/20227,790,000 shares $6.93 million -4.0%N/A6.5 $0.89 11/30/20228,110,000 shares $8.35 million -8.2%N/A6.9 $1.03 11/15/20228,830,000 shares $9.01 million +2.7%N/A8.6 $1.02 10/31/20228,600,000 shares $8.77 million -15.6%N/A6.7 $1.02 10/15/202210,190,000 shares $9.21 million +12.2%N/A7.4 $0.90 9/30/20229,080,000 shares $7.91 million +3.2%N/A5.1 $0.87 9/15/20228,800,000 shares $9.06 million +1.6%N/A4.9 $1.03 8/31/20228,660,000 shares $9.27 million -17.0%N/A4.5 $1.07 8/15/202210,430,000 shares $12.93 million +3.6%N/A4.3 $1.24 7/31/202210,070,000 shares $10.77 million +0.4%N/A3.2 $1.07 7/15/202210,030,000 shares $10.13 million -11.2%N/A2.6 $1.01 6/30/202211,290,000 shares $10.35 million -14.5%N/A2.7 $0.92 6/15/202213,210,000 shares $12.90 million -2.2%N/A2.5 $0.98 5/31/202213,500,000 shares $15.53 million -9.8%N/A2.4 $1.15 5/15/202214,960,000 shares $18.40 million +5.4%N/A2.7 $1.23 4/30/202214,200,000 shares $20.02 million -4.8%N/A2.6 $1.41 4/15/202214,910,000 shares $25.94 million +10.8%N/A2.9 $1.74 3/31/202213,460,000 shares $22.34 million -10.8%N/A2.5 $1.66 3/15/202215,090,000 shares $20.67 million +0.7%N/A3.1 $1.37 2/28/202214,990,000 shares $22.34 million -2.2%N/A2.9 $1.49 2/15/202215,320,000 shares $26.20 million -10.8%N/A2.6 $1.71 1/31/202217,170,000 shares $25.58 million +6.5%N/A2.3 $1.49 1/15/202216,130,000 shares $26.45 million +8.9%N/A2.2 $1.64 12/31/202114,810,000 shares $25.92 million +6.2%N/A2 $1.75 12/15/202113,950,000 shares $25.39 million -4.6%N/A1.9 $1.82 11/30/202114,620,000 shares $29.82 million -15.5%N/A2 $2.04 11/15/202117,300,000 shares $41.17 million +28.1%N/A2.5 $2.38 10/29/202113,510,000 shares $29.86 million -7.3%N/A2.4 $2.21 10/15/202114,580,000 shares $32.66 million +2.5%N/A2.7 $2.24 9/30/202114,220,000 shares $32.71 million -10.9%N/A2.5 $2.30 9/15/202115,950,000 shares $38.60 million -14.4%N/A2.9 $2.42 8/31/202118,630,000 shares $49.74 million +9.0%N/A3.3 $2.67 8/13/202117,100,000 shares $49.59 million -2.7%N/A2.7 $2.90 7/30/202117,580,000 shares $46.06 million +12.8%N/A2.8 $2.62Silicon Valley Gold Rush (Ad)A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.Gates and Altman are betting big—see why 7/15/202115,580,000 shares $41.60 million +7.5%N/A2.3 $2.67 6/30/202114,490,000 shares $41.44 million +4.9%N/A1.9 $2.86 6/15/202113,820,000 shares $42.57 million +16.2%N/A1.7 $3.08 5/28/202111,890,000 shares $38.17 million -13.6%N/A1 $3.21 5/14/202113,760,000 shares $33.44 million -9.7%5.8%1.1 $2.43 4/30/202115,230,000 shares $41.58 million +10.3%6.4%0.7 $2.73 4/15/202113,810,000 shares $35.91 million +17.9%5.8%0.6 $2.60 3/31/202111,710,000 shares $39.93 million -17.5%6.6%0.5 $3.41 3/15/202114,200,000 shares $63.05 million +26.1%8.2%0.6 $4.44 2/26/202111,260,000 shares $34.68 million -1.5%4.9%0.5 $3.08 2/12/202111,430,000 shares $41.95 million +36.9%5.0%0.5 $3.67 1/29/20218,350,000 shares $15.95 million -8.3%3.6%0.5 $1.91 1/15/20219,110,000 shares $16.40 million -1.5%4.0%0.8 $1.80 12/31/20209,250,000 shares $12.67 million -27.9%4.0%1 $1.37 12/15/202012,820,000 shares $16.54 million -19.4%5.6%1.7 $1.29 11/30/202015,910,000 shares $21.16 million +11.3%6.9%2.3 $1.33 11/15/202014,290,000 shares $16.15 million -2.7%6.2%2.9 $1.13 10/30/202014,690,000 shares $17.92 million +1.2%7.6%3.8 $1.22 10/15/202014,520,000 shares $17.42 million -4.4%7.5%5.3 $1.20 9/30/202015,180,000 shares $15.94 million -4.7%7.9%5.1 $1.05 9/15/202015,930,000 shares $17.12 million +4.3%8.2%5 $1.08 8/31/202015,280,000 shares $19.25 million +1.7%7.9%4 $1.26 8/14/202015,030,000 shares $22.09 million -1.3%7.8%2.9 $1.47 7/31/202015,230,000 shares $18.73 million +9.2%7.9%2.6 $1.23 7/15/202013,950,000 shares $22.04 million +4.9%7.2%2.4 $1.58 6/30/202013,300,000 shares $20.75 million -0.3%6.9%2.3 $1.56 6/15/202013,340,000 shares $26.28 million +2.8%7.8%2.3 $1.97 5/29/202012,980,000 shares $22.59 million +2.3%7.6%2.4 $1.74 5/15/202012,690,000 shares $18.40 million +8.2%7.4%2.8 $1.45 OGI Short Interest - Frequently Asked Questions What is Organigram's current short interest? Short interest is the volume of Organigram shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 5,490,000 shares of OGI short. 6.63% of Organigram's shares are currently sold short. Learn More on Organigram's current short interest. What is a good short interest ratio for Organigram? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OGI shares currently have a short interest ratio of 6.0. Learn More on Organigram's short interest ratio. Which institutional investors are shorting Organigram? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Organigram: Group One Trading LLC, Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Organigram? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.63% of Organigram's floating shares are currently sold short. Is Organigram's short interest increasing or decreasing? Organigram saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 5,490,000 shares, a decline of 9.7% from the previous total of 6,080,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Organigram's float size? Organigram currently has issued a total of 126,274,000 shares. Some of Organigram's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Organigram currently has a public float of 82,780,000 shares. How does Organigram's short interest compare to its competitors? 6.63% of Organigram's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Organigram: Cogent Biosciences, Inc. (13.79%), Relay Therapeutics, Inc. (11.46%), Valneva SE (0.01%), Tyra Biosciences, Inc. (12.81%), Kura Oncology, Inc. (11.81%), Opthea Limited (0.36%), Prothena Co. plc (18.64%), UroGen Pharma Ltd. (22.73%), Stoke Therapeutics, Inc. (26.73%), Maravai LifeSciences Holdings, Inc. (5.56%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Organigram stock? Short selling OGI is an investing strategy that aims to generate trading profit from Organigram as its price is falling. OGI shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Organigram? A short squeeze for Organigram occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OGI, which in turn drives the price of the stock up even further. How often is Organigram's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OGI, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies Cogent Biosciences Short Squeeze Relay Therapeutics Short Squeeze Valneva Short Squeeze Tyra Biosciences Short Squeeze Kura Oncology Short Squeeze Opthea Short Squeeze Prothena Short Squeeze UroGen Pharma Short Squeeze Stoke Therapeutics Short Squeeze Maravai LifeSciences Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OGI) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredThe Worst Year in American Financial History?Economist Explains: The Curse on the U.S. Dollar Yes, there is a Curse on the U.S. Dollar... and it's behin...Stansberry Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organigram Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organigram With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OGI Stock Free OGI Stock Alerts